/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | MDPediatrix Medical Gr |
|---|---|
| Last close | $31.49close 2026-11-09 |
| Change % | +0.64%close 2026-11-09 |
| Market cap | $2.5Bclose 2026-11-09 |
| P/E | 16.2FY to 2025-12-31 |
| Revenue | $1.9B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerIncludingAssessedTax As ofFY ending 2025-12-31 Filing10-K · 0001193125-26-058074 · filed 2026-02-19 Open the filing on EDGAR →Open the XBRL payload → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -4.9%FY to 2025-12-31 |
| Net income | $165M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 Filing10-K · 0001193125-26-058074 · filed 2026-02-19 Open the filing on EDGAR →Open the XBRL payload →CitePediatrix Medical Group, Inc. (MD), us-gaap:NetIncomeLoss: 165,388,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001193125-26-058074, filed 2026-02-19. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000893949/us-gaap/NetIncomeLoss.json |
| Net margin | 8.6%FY to 2025-12-31 |
| EPS (diluted) | $1.94⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001193125-26-058074 · filed 2026-02-19 Open the filing on EDGAR →Open the XBRL payload →CitePediatrix Medical Group, Inc. (MD), us-gaap:EarningsPerShareDiluted: 1.94 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001193125-26-058074, filed 2026-02-19. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000893949/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | not scored |
| Altman Z-ScoreUNVALIDATED | not scored |
| Beneish M-ScoreUNVALIDATED | not scored |
| Next earnings | 02-13 → 02-23 |